The Effect of Fosinopril on Plasma Endothelin-1 and Calcitonin Gene-Related Peptide Levels in Patients with Chronic Heart Failure

Chen Sai-yon

2007-01-01

Abstract:Objective To examine the levels of plasma endothelin-1 (ET-1), angiotensinII (AngⅡ)and calcitonin gene-related peptide (CGRP) levels, and study the effect of Fosinopril on the above parameters in patients with chronic heart failure(CHF). Methods Plasma levels of ET-1,AngⅡ and CGRP were detected in 40 normal controls and 90 patients with CHF.Ninity patients with CHF were randomized to receive Fosinopril 10 mg in addition to Conventional therapy,or only conventional therapy for 14 days. Plasma ET-1,AngⅡ and CGRP were detected at baseline and 14 days after treatment. Left ventricular ejection fractions(LVEF) were measured before and after 14 days of treatment. Results Compared with normal controls.CHF patients had increased in levels of plasma ET-1 and AngⅡ(P0.01). Plasma CGRP had decreased(P0.01). LVEF was significantly negatively correlated with the levels of ET-1(r=-0.71,P0.01),and AngⅡ(r=-0.62,P0.01),ET-1 positively correlated AngⅡ(r=0.69,P0.01),administration of Fosinopril was associated with the decreasing of the levels of plasma ET-1 and increasing the levels of CGRP(P0.01).LVEF increastd after 14 days of treatment by Fosinopril(P0.05). No significant changes were found on conventional therapy(P0.05). Conclusion The levels of plasma ET-1,AngⅡ and CGRP are abnormal in CHF patients. ET-1 and AngⅡ were negatively correlated with LVEF.Fosinopril can modulate the levels of ET-1,AngⅡ and CGRP, or improve LVEF in CHF patients.